Medisof Diagnostic S.R.L.
- Address
- lock Available on a paid plan
Immune System Diseases
At Medisof Diagnostic S.R.L., researchers are advancing treatments for systemic lupus erythematosus, an autoimmune condition that can affect multiple organs. The trials aim to evaluate the effectiveness of a novel oral inhibitor, seeking to improve disease control and quality of life for patients.
- Testing the impact of targeted pathway inhibition on disease activity
- Assessing safety and tolerability in a diverse patient population
- Measuring improvements in standardized disease activity scores
The site in Craiova, Romania, conducts three active studies with two investigators, focusing on innovative therapies for immune‑mediated disorders.
Musculoskeletal Diseases
Clinical research at this center also addresses psoriatic arthritis and axial spondyloarthritis, two inflammatory joint diseases that limit mobility. Studies compare new oral agents to placebo to determine how they can reduce joint pain, swelling, and structural damage.
- Evaluating symptom relief and functional gains
- Monitoring imaging markers of spinal inflammation
- Investigating outcomes in patients who have not received biologic therapies
Through collaborative efforts, the team seeks to expand therapeutic options for musculoskeletal conditions across Europe.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Janssen Cilag International1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medisof Diagnostic S.R.L.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 randomized, placebo-controlled, double-blind, parallel-group program to evaluate efficacy and safety of filgotinib in adult subjects with active axial spondyloarthritis | Alfasigma S.p.A. | Phase III | Not Recruiting | Jun 2023 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Deucravacitinib | 2 | Unknown | 2021-10-20 | 2023-05-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.